(ACGL) Arch Capital - Overview
Exchange: NASDAQ •
Country: Bermuda •
Currency: USD •
Type: Common Stock •
ISIN: BMG0450A1053
Stock:
Total Rating 53
Risk 69
Buy Signal 0.40
| Risk 5d forecast | |
|---|---|
| Volatility | 23.4% |
| Relative Tail Risk | -1.89% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.27 |
| Alpha | -0.83 |
| Character TTM | |
|---|---|
| Beta | 0.415 |
| Beta Downside | 0.630 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.43% |
| CAGR/Max DD | 0.64 |
EPS (Earnings per Share)
Revenue
Description: ACGL Arch Capital
Arch Capital Group Ltd., together with its subsidiaries, provides insurance, reinsurance, and mortgage insurance products in the United States, Canada, Bermuda, the United Kingdom, Europe, and Australia. The Insurance segment offers commercial automobile; commercial multiperil; financial and professional line liability; admitted, excess, and surplus casualty lines; property and short-tail specialty; workers compensation; casualty; marine and aviation; excess and surplus casualty; construction and national accounts; alternative market risks and employer's liability; travel, accident, and health; contract and commercial surety coverage; and other insurance products, as well as Lloyd's syndicates; programs; and warranty and lenders solutions. Its Reinsurance segment provides reinsurance products for casualty; marine and aviation; property catastrophe; property excluding property catastrophe; and other specialty products. The Mortgage segment offers U.S. primary mortgage insurance business written predominantly on loans sold to the Federal National Mortgage Association and Federal Home Loan Mortgage Corporation; reinsurance and underwriting services related to the U.S. credit-risk transfer business and other U.S. mortgage reinsurance transactions; and international mortgage insurance and reinsurance business covering loans. It markets its products through a group of licensed independent retail and wholesale brokers. The company was formerly known as Risk Capital Holdings, Inc. Arch Capital Group Ltd. was founded in 1995 and is headquartered in Pembroke, Bermuda.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 4.40b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -0.20 > 1.0 |
| NWC/Revenue: 8.00% < 20% (prev -222.7%; Δ 230.7% < -1%) |
| CFO/TA 0.09 > 3% & CFO 6.17b > Net Income 4.40b |
| Net Debt (1.74b) to EBITDA (5.38b): 0.32 < 3 |
| Current Ratio: 1.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (376.1m) vs 12m ago -1.75% < -2% |
| Gross Margin: 39.22% > 18% (prev 0.35%; Δ 3887 % > 0.5%) |
| Asset Turnover: 28.01% > 50% (prev 23.88%; Δ 4.13% > 0%) |
| Interest Coverage Ratio: 35.05 > 6 (EBITDA TTM 5.38b / Interest Expense TTM 148.0m) |
Altman Z'' 2.63
| A: 0.02 (Total Current Assets 8.99b - Total Current Liabilities 7.44b) / Total Assets 67.06b |
| B: 0.40 (Retained Earnings 27.05b / Total Assets 67.06b) |
| C: 0.08 (EBIT TTM 5.19b / Avg Total Assets 68.98b) |
| D: 0.63 (Book Value of Equity 27.05b / Total Liabilities 42.85b) |
| Altman-Z'' Score: 2.63 = A |
Beneish M
| DSRI: 0.44 (Receivables 7.99b/16.05b, Revenue 19.32b/16.93b) |
| GMI: 0.89 (GM 39.22% / 35.07%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.14 (Revenue 19.32b / 16.93b) |
| TATA: -0.03 (NI 4.40b - CFO 6.17b) / TA 67.06b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of ACGL shares?
As of March 04, 2026, the stock is trading at USD 100.48 with a total of 1,239,406 shares traded.
Over the past week, the price has changed by +1.31%, over one month by +3.78%, over three months by +8.37% and over the past year by +8.07%.
Over the past week, the price has changed by +1.31%, over one month by +3.78%, over three months by +8.37% and over the past year by +8.07%.
Is ACGL a buy, sell or hold?
Arch Capital has received a consensus analysts rating of 4.14.
Therefore, it is recommended to buy ACGL.
- StrongBuy: 6
- Buy: 4
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ACGL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 109.3 | 8.8% |
| Analysts Target Price | 109.3 | 8.8% |
ACGL Fundamental Data Overview February 28, 2026
P/E Trailing = 8.5905
P/E Forward = 9.3809
P/S = 1.8132
P/B = 1.4968
P/EG = 2.24
Revenue TTM = 19.32b USD
EBIT TTM = 5.19b USD
EBITDA TTM = 5.38b USD
Long Term Debt = 2.73b USD (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = 2.73b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.74b USD (from netDebt column, last quarter)
Enterprise Value = 37.87b USD (36.14b + Debt 2.73b - CCE 993.0m)
Interest Coverage Ratio = 35.05 (Ebit TTM 5.19b / Interest Expense TTM 148.0m)
EV/FCF = 6.18x (Enterprise Value 37.87b / FCF TTM 6.13b)
FCF Yield = 16.18% (FCF TTM 6.13b / Enterprise Value 37.87b)
FCF Margin = 31.72% (FCF TTM 6.13b / Revenue TTM 19.32b)
Net Margin = 22.77% (Net Income TTM 4.40b / Revenue TTM 19.32b)
Gross Margin = 39.22% ((Revenue TTM 19.32b - Cost of Revenue TTM 11.74b) / Revenue TTM)
Gross Margin QoQ = 52.29% (prev 40.00%)
Tobins Q-Ratio = 0.56 (Enterprise Value 37.87b / Total Assets 67.06b)
Interest Expense / Debt = 1.39% (Interest Expense 38.0m / Debt 2.73b)
Taxrate = 14.50% (210.0m / 1.45b)
NOPAT = 4.44b (EBIT 5.19b * (1 - 14.50%))
Current Ratio = 1.21 (Total Current Assets 8.99b / Total Current Liabilities 7.44b)
Debt / Equity = 0.11 (Debt 2.73b / totalStockholderEquity, last quarter 24.21b)
Debt / EBITDA = 0.32 (Net Debt 1.74b / EBITDA 5.38b)
Debt / FCF = 0.28 (Net Debt 1.74b / FCF TTM 6.13b)
Total Stockholder Equity = 23.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.38% (Net Income 4.40b / Total Assets 67.06b)
RoE = 19.02% (Net Income TTM 4.40b / Total Stockholder Equity 23.13b)
RoCE = 20.07% (EBIT 5.19b / Capital Employed (Equity 23.13b + L.T.Debt 2.73b))
RoIC = 17.98% (NOPAT 4.44b / Invested Capital 24.67b)
WACC = 7.00% (E(36.14b)/V(38.86b) * Re(7.44%) + D(2.73b)/V(38.86b) * Rd(1.39%) * (1-Tc(0.15)))
Discount Rate = 7.44% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.49%
[DCF] Terminal Value 84.58% ; FCFF base≈6.33b ; Y1≈7.80b ; Y5≈13.29b
[DCF] Fair Price = 778.0 (EV 281.04b - Net Debt 1.74b = Equity 279.31b / Shares 359.0m; r=7.00% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 59.63 | EPS CAGR: 30.44% | SUE: 1.38 | # QB: 5
Revenue Correlation: 95.99 | Revenue CAGR: 27.14% | SUE: 4.0 | # QB: 3
EPS next Quarter (2026-06-30): EPS=2.49 | Chg7d=-0.007 | Chg30d=-0.032 | Revisions Net=-9 | Analysts=18
EPS current Year (2026-12-31): EPS=9.37 | Chg7d=-0.013 | Chg30d=+0.008 | Revisions Net=-1 | Growth EPS=-4.7% | Growth Revenue=+2.1%
EPS next Year (2027-12-31): EPS=10.10 | Chg7d=-0.018 | Chg30d=-0.070 | Revisions Net=-2 | Growth EPS=+7.8% | Growth Revenue=+3.9%
[Analyst] Revisions Ratio: -0.82 (1 Up / 10 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -3.7% (Discount Rate 7.9% - Earnings Yield 11.6%)
[Growth] Growth Spread = +4.8% (Analyst 1.1% - Implied -3.7%)
P/E Forward = 9.3809
P/S = 1.8132
P/B = 1.4968
P/EG = 2.24
Revenue TTM = 19.32b USD
EBIT TTM = 5.19b USD
EBITDA TTM = 5.38b USD
Long Term Debt = 2.73b USD (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = 2.73b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.74b USD (from netDebt column, last quarter)
Enterprise Value = 37.87b USD (36.14b + Debt 2.73b - CCE 993.0m)
Interest Coverage Ratio = 35.05 (Ebit TTM 5.19b / Interest Expense TTM 148.0m)
EV/FCF = 6.18x (Enterprise Value 37.87b / FCF TTM 6.13b)
FCF Yield = 16.18% (FCF TTM 6.13b / Enterprise Value 37.87b)
FCF Margin = 31.72% (FCF TTM 6.13b / Revenue TTM 19.32b)
Net Margin = 22.77% (Net Income TTM 4.40b / Revenue TTM 19.32b)
Gross Margin = 39.22% ((Revenue TTM 19.32b - Cost of Revenue TTM 11.74b) / Revenue TTM)
Gross Margin QoQ = 52.29% (prev 40.00%)
Tobins Q-Ratio = 0.56 (Enterprise Value 37.87b / Total Assets 67.06b)
Interest Expense / Debt = 1.39% (Interest Expense 38.0m / Debt 2.73b)
Taxrate = 14.50% (210.0m / 1.45b)
NOPAT = 4.44b (EBIT 5.19b * (1 - 14.50%))
Current Ratio = 1.21 (Total Current Assets 8.99b / Total Current Liabilities 7.44b)
Debt / Equity = 0.11 (Debt 2.73b / totalStockholderEquity, last quarter 24.21b)
Debt / EBITDA = 0.32 (Net Debt 1.74b / EBITDA 5.38b)
Debt / FCF = 0.28 (Net Debt 1.74b / FCF TTM 6.13b)
Total Stockholder Equity = 23.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.38% (Net Income 4.40b / Total Assets 67.06b)
RoE = 19.02% (Net Income TTM 4.40b / Total Stockholder Equity 23.13b)
RoCE = 20.07% (EBIT 5.19b / Capital Employed (Equity 23.13b + L.T.Debt 2.73b))
RoIC = 17.98% (NOPAT 4.44b / Invested Capital 24.67b)
WACC = 7.00% (E(36.14b)/V(38.86b) * Re(7.44%) + D(2.73b)/V(38.86b) * Rd(1.39%) * (1-Tc(0.15)))
Discount Rate = 7.44% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.49%
[DCF] Terminal Value 84.58% ; FCFF base≈6.33b ; Y1≈7.80b ; Y5≈13.29b
[DCF] Fair Price = 778.0 (EV 281.04b - Net Debt 1.74b = Equity 279.31b / Shares 359.0m; r=7.00% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 59.63 | EPS CAGR: 30.44% | SUE: 1.38 | # QB: 5
Revenue Correlation: 95.99 | Revenue CAGR: 27.14% | SUE: 4.0 | # QB: 3
EPS next Quarter (2026-06-30): EPS=2.49 | Chg7d=-0.007 | Chg30d=-0.032 | Revisions Net=-9 | Analysts=18
EPS current Year (2026-12-31): EPS=9.37 | Chg7d=-0.013 | Chg30d=+0.008 | Revisions Net=-1 | Growth EPS=-4.7% | Growth Revenue=+2.1%
EPS next Year (2027-12-31): EPS=10.10 | Chg7d=-0.018 | Chg30d=-0.070 | Revisions Net=-2 | Growth EPS=+7.8% | Growth Revenue=+3.9%
[Analyst] Revisions Ratio: -0.82 (1 Up / 10 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -3.7% (Discount Rate 7.9% - Earnings Yield 11.6%)
[Growth] Growth Spread = +4.8% (Analyst 1.1% - Implied -3.7%)